- From: Dobson, Stephen <Stephen.Dobson@pfizer.com>
- Date: Thu, 4 Jan 2007 20:51:24 -0500
- To: <public-hcls-dse@w3.org>, <public-hcls-dse-request@w3.org>
- Message-ID: <7A20EEC75BBEE542B9E40B92F58E8C5305A3A21A@groamrexm03.amer.pfizer.com>
Hi All, I've made a first start at describing some of the context around vital signs if we can discuss tomorrow I'll add to this and post on the site. Apologies for not getting out sooner. Cheers Stephen. -----Original Message----- From: public-hcls-dse-request@w3.org [mailto:public-hcls-dse-request@w3.org] On Behalf Of Forsberg, Kerstin L Sent: Friday, December 15, 2006 9:44 AM To: public-hcls-dse@w3.org Subject: Clinical Trial Ontology Hi, on our wikipage http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy/ in the section Related resources I have added links to - The Workshop on Clinical Trial Ontology - From XML to RDF: how semantic web technologies may change the design of clinical standards? A posting on CDISC discussion forum I did last year with a link to the Nature article I briefly mentioned. Cheers Kerstin ---------------------------------------------------------------------- LEGAL NOTICE Unless expressly stated otherwise, this message is confidential and may be privileged. It is intended for the addressee(s) only. Access to this E-mail by anyone else is unauthorized. If you are not an addressee, any disclosure or copying of the contents of this E-mail or any action taken (or not taken) in reliance on it is unauthorized and may be unlawful. If you are not an addressee, please inform the sender immediately.
Attachments
- application/vnd.ms-powerpoint attachment: Vital Sign Context.ppt
Received on Friday, 5 January 2007 01:51:37 UTC